Michael Arenberg
Direttore operativo presso IMAGO BIOSCIENCES, INC.
Posizioni attive di Michael Arenberg
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMAGO BIOSCIENCES, INC. | Direttore operativo | 23/03/2022 | - |
Storia della carriera di Michael Arenberg
Precedenti posizioni note di Michael Arenberg
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| DURECT CORPORATION | Direttore Finanziario/CFO | 15/10/2018 | 17/03/2022 |
| Contatto Relazioni con gli Investitori | 01/01/1999 | 17/03/2022 | |
| Corporate Officer/Principal | 17/07/2009 | 15/10/2018 | |
| Segretario Aziendale | - | 17/03/2022 | |
IntraEAR, Inc.
 IntraEAR, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., IntraEAR, Inc. is a company that develops drug delivery devices for inner-ear maladies. The company is based in Greenwood Village, CO. IntraEAR was acquired by DURECT Corp. on October 06, 1999. The company was founded by Dan K. Arenberg, Michael H. Arenberg. | Fondatore | 01/01/1996 | 01/01/1999 |
| Vendite & Marketing | 01/01/1996 | 01/01/1999 |
Formazione di Michael Arenberg
| University of Denver | Graduate Degree |
| Leavey School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Director of Finance/CFO | 1 |
| Investor Relations Contact | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DURECT CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
IntraEAR, Inc.
IntraEAR, Inc. Medical SpecialtiesHealth Technology Part of DURECT Corp., IntraEAR, Inc. is a company that develops drug delivery devices for inner-ear maladies. The company is based in Greenwood Village, CO. IntraEAR was acquired by DURECT Corp. on October 06, 1999. The company was founded by Dan K. Arenberg, Michael H. Arenberg. | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
- Borsa valori
- Insiders
- Michael Arenberg
- Esperienza
